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In the present investigation, a series of 3-aryl-4-methoxy N-alkyl maleimide 5a-l have been synthesized and screened for 
their antimicrobial activity against one Gram positive bacteria (S. aureus), one Gram negative bacteria (E. coli) and fungal 
strains (C. albicans, C. tropicalis,  A. niger and A. clavatus). The structures of the compounds have been substantiated by 
their IR, NMR, mass and elemental analysis. The minimum inhibitory concentrations (MICs) of synthesized maleimides 
have been determined by broth microdilution method. Of the newly synthesized maleimides, compounds 5c, 5f, 5h, 5i, 5k 
and 5l registered significant activity against the tested microorganisms. 
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The progression of antimicrobial resistance to the 
currently marketed drugs represents a great threat to 
modern society
1
. This situation necessitates 
continuing research for the development of new and 
more potent antimicrobial agent. Medicinal chemists 
are working very hard to design and synthesise the 
new molecules which possesses more effective and 
less toxicity, with unusual mode of action than that of 
existing drug. 
The maleimide is a privileged heterocyclic skeleton 
as they are endowed with several biological 
and pharmaceutical activities
2
. In recent times, 
maleimides have received considerable attention due 














 and nematicidal 
activities
12
. Some of the derivatives of maleimides are 












among others. They are of great interest in area of 
bioconjugate chemistry and biotechnology due to its 
reaction specificity with the biothiols via Micheal 
type of addition reaction
18
. Some of its derivatives are 
reported in the literature as a potent inhibitor of the 
protein kinase
19
 and antiproliferative activities
20
. 
Encouraged by potential clinical applications of 
maleimides (Figure 1) and in continuation of our 
previous research on maleimides
21,22
 here in we report 
a series of novel 3-aryl-4-methoxy N-alkyl maleimide 
5a-l and evaluation of their antimicrobial activity. 
Result and Discussion 
Chemistry 
The synthetic route of maleimides is outlined in 
Scheme 1. Compound 3a, 3c, 4a and 4c were prepared 
according to reported method
23
. A Modified procedure 
than literature
23
 was used for synthesise of pyruvate 
2a-c. P-substituted benzyl cyanide 1a-c were condensed 
with diethyl oxalate in THF using sodium hydride to 
get pyruvates 2a-c which on methylation with dimethyl 
sulphate (DMS), followed by hydrolysis with con. 
H2SO4 furnished 3-aryl-4-methoxy maleic anhydrides 
4a-c.The target compounds 5a-l were synthesized by 
Figure 1 — Structures of some biologically active maleimides and 
synthesized compounds 5a-l 




treating 3-aryl-4-methoxy maleic anhydrides 4a-c with 
corresponding amine, in ethanol at reflux temperature 
with excellent yields. 
 
Spectroscopic analysis 
The structures of compound 5a-l were 
substantiated by their IR, NMR, mass and elemental 
analysis. The IR spectrum of compound 5a-l showed 
stretching frequencies in the range of 1697 to 1712 
cm
−1
 attributed to carbonyl groups. 
1
H NMR spectra 
of compound 5a-l showed signal in the region of  
1.24 to 4.71 ppm corresponds to the protons of N-alky 
substituent. In 
13
C NMR spectra, aromatic carbons 
appeared around  120.80 to 136 ppm. Two signals 
for imide carbonyl carbons appeared around  165.41 
and 171.73 ppm. Elemental analysis was found in 
agreement with molecular formula. 
 
Pharmacology 
All maleimides were screened against panel of one 
Gram positive bacteria (Staphylococcus aureus MTCC 
96) and one Gram negative bacteria (Escherichia coli 
MTCC 443) and four fungal strains (Candida albicans 
MTCC 227, Candida tropicalis MTCC 184, Aspergillus 
niger MTCC 282 and Aspergillus clavatus MTCC 
1323),. The minimum inhibitory concentrations (MICs) 
of synthesized maleimides were carried out by broth 
microdilution method as described by Rattan
24
. 
Ampicillin and Griseofulvin were used as reference for 
bacteria and fungi respectively. 
In vitro antimicrobial activity 
Reviewing of antimicrobial activities of maleimides 
(Table 1) indicated that, In case of Gram positive 





= CH2Ph) registered remarkable antibacterial 
activity (MIC = 125 μg/mL) compared to ampicillin 














= CH2CH2OH) showed equal antifungal activity to 
the ampicillin (MIC = 250 μg/mL). While in case  





= CH2Ph) showed comparable activity 
to that of standard ampicillin (MIC = 125 μg/mL). 





= CH2CH2OH) showed good antifungal 
activity (MIC = 250 μg/mL) against Candida albicans 
compared to the griseofulvin (MIC = 500 μg/mL). 









= CH2Ph) showed equal antifungal 
activity (MIC = 500 μg/mL) to the griseofulvin against 
same species. Tested compounds exhibited marginal or 
no significant activity against Candida tropicalis, 




Materials and General Synthetic methods 
Gallenkamp melting point apparatus was used to 
check the Melting points and are uncorrected. IR 
spectra were recorded as KBr discs on a Shimadzu 
 
 
Scheme 1 — Synthetic pathway of compounds 5a-l 
 




FTIR-408 spectrophotometer. The 
1
H (300 MHz) and 
13
C (75 MHz) NMR spectra were measured with Varian 
NMR Mercury-300. Chemical shifts were reported as  
δ values (ppm) relative to internal standard TMS. Mass 
spectra were performed on a Shimadzu LC-MS mass 
spectrometer with an ionization potential of 70 eV. 
Elemental analyses (C, H and N) were carried out on 
Thermo Finnigan Eager 300 EA 1112 series analyser. 
Thin layer chromatography (TLC) was used to monitor 
the progress of reactions. 
 
General procedure for synthesis of compound 2a-c 
A solution of p-substituted benzyl cyanide 1a-c 
(0.039 mol) in THF (25 mL) was slowly added to 
round bottom flask containing slurry of sodium 
hydride (60% mineral oil, 0.04 mol) in THF (25 mL) 
at RT followed by dropwise addition of diethyl 
oxalate (0.045 mol). The reaction mixture was stirred 
for 2 h. It was concentrated on rotavapour and poured 
into cold water (150 mL). On acidification by 
hydrochloric acid, faint yellow solid obtained was 
filtered and recrystallized from ethanol. 
 










H NMR: (300 MHz, CDCl3): δ 1.34 (t, 3H, CH3, J = 
7.2 Hz), 4.31 (q, 2H, CH2, J = 7.2 Hz), 7.48 (d, 2H, 
ArH, J = 8.4 Hz), 7.73 (d, 2H, ArH, J = 8.4 Hz), 7.55 
(bs, 1H, OH); MS (70 eV): m/z 250 [M-H]
+
. Anal. 
Calcd for C12H10ClNO3: C, 57.27; H, 4.01; N, 5.57. 
Found: C, 57.39; H, 4.19; N, 5.66%. 
 
Ethyl 3-cyano-2-hydroxy-3-(4-methoxyphenyl) acrylate, 




General procedure for synthesis of compound 3a-c 
Dimethyl sulphate (2.76 g, 0.021mol) was slowly 
added to stirred mixture of 2a-c (0.021 mol) and 
anhydrous potassium carbonate (0.024 mol) in dry 
acetone (55 mL). It was reflux for 2 h, cooled and 
filtered. On evaporation of acetone, compound 3a-c 
was obtained as faint yellow oil is obtained. 
 
Ethyl 3-(4-chlorophenyl)-3-cyano-2-methoxyacrylate, 




H NMR: (300 
MHz, CDCl3): δ 1.37 (t, 3H, CH3), 4.41 (q, 2H, CH2), 
3.90 (s, 3H, OCH3), 7.55 (d, 2H, ArH, J = 8.4 Hz), 
7.77 (d, 2H, ArH, J = 8.4 Hz); MS (70 eV): m/z 266 
[M+H]
+
. Anal. Calcd for C13H12ClNO3: C, 58.77; H, 
4.55; N, 5.27. Found: C, 58.93; H, 4.68; N, 5.46%. 
 
General procedure for synthesis of compound 4a-c 
A solution of 3a-c (5 g) in acetic acid (60 mL)  
and water (40 mL) was treated drop wise with H2SO4 
(50 mL). The temperature of exothermic reaction was 
maintained at 100°C for 30 min. The reaction mixture 
was then cooled, diluted with cold water (150 mL) and 
extracted with ether (3 × 70 mL). The combined ether 
extracts were washed with 5% KOH, and aqueous 
extracts were then acidified with dilute H2SO4 and 
extracted with ether. On evaporation of ether, 4a-c  
was obtained as solid and purified by column 
chromatography using hexane: ethyl acetate (8:2). 
Table 1 — In vitro antimicrobial activity (MIC in μg/mL) of compounds 5a-l 
Compd Bacteria Fungus 
S. a. E. c. C. a. C. t. A. n. A. c. 
5a 1000 250 − − − − 
5b − − 1000 250 1000 − 
5c 500 250 500 500 − 500 
5d − 1000 1000 − − − 
5e 1000 − − 1000 250 500 
5f 250 500 1000 − 500 − 
5g − 1000 − 500 − − 
5h 500 − 500 1000 − 1000 
5i 125 125 1000 500 250 250 
5j − 500 − − − − 
5k 250 − − − 500 250 
5l 250 250 250 500 1000 1000 
Ampicillin 250 125 NA NA NA NA 
Griseofulvin NA NA 500 100 100 100 
S.a. Staphylococcus aureus MTCC 96, E.c. Escherichia coli MTCC 443, C.a. Candida albicans MTCC 227, C.t. Candida 
tropicalisMTCC 184, A.n. Aspergillus nigerMTCC 282, A.c. Aspergillus clavatusMTCC 1323 (-): Inactive, NA: Not Applicable 
 









H NMR: (300 








H NMR (300 MHz, CDCl3): δ 4.43 (s, 3H, OCH3), 
7.43 (d, 2H, ArH, J = 8.4 Hz), 7.95 (d, 2H, ArH, J= 
8.4 Hz); MS (70 eV): m/z 239 [M+H]
+
; HRMS: 
Found: m/z 239.0106 [M+H]
+
. C11H8ClO4 requires: 
239.0111. Anal. Calcd for C11H7ClO4: C, 55.37; H, 
2.96. Found: C, 55.48; H, 2.78%. 
 
3-Methoxy-4-(4-methoxyphenyl)furan-2,5-dione, 4c: 




H NMR: (300 
MHz, CDCl3): δ 3.80 (s, 3H), 4.26 (s, 3H, OCH3), 
7.07 (d, 2H, ArH), 7.84 (d, 2H, ArH). 
 
General procedure for synthesis of 3-aryl-4-
methoxy N-alkyl maleimides, 5a-l 
3-Aryl-4-methoxy maleic anhydrides 4a-c (4.2 
mmol) were refluxed with amines (4.2 mmol), in 
ethanol (10 mL) for 20-30 minute. After completion 
of reaction (checked by TLC), reaction mixture was 
concentrated in vaccuo. On aqueous work up, solid 
separated was filtered to furnish corresponding 
maleimide. It was purified by column chromate-
graphy using hexane: ethyl acetate (7:3). 
 
3-Methoxy-1-methyl-4-phenyl-1H-pyrrole-2,5-dione, 




H NMR: (300 MHz, CDCl3): δ 2.91 (s, 3H), 4.16 (s, 
3H), 7. 34- 7.76 (m, 5H); 
13
C NMR: (300 MHz, 
CDCl3): δ 23.45, 60.18, 113.17, 128.20, 128.65, 
129.04, 130.39, 166.18, 170.73, 171.38; MS (70 eV): 
m/z 218 [M+H]
+
. Anal. Calcd for C12H11NO3: C, 









H NMR: (300 MHz, CDCl3): δ 3.04 (s, 
3H), 4.31 (s, 3H), 7.45 (d, 2H, J = 8.4 Hz), 7. 84 (d, 
2H, J = 8.4 Hz); 
13
C NMR: (300 MHz, CDCl3): δ 
23.39, 60.40, 111.92, 127.00, 128.48, 130.02, 134.38, 
151.69, 165.80, 169.78; MS (70 eV): m/z 252 
[M+H]
+
. Anal. Calcd for C12H10ClNO3: C, 57.27; H, 
4.01; N, 5.57. Found: C, 57.53; H, 4.18; N, 5.62%. 
 
3-Methoxy-4-(4-methoxyphenyl)-1-methyl-1H-





H NMR: (300 MHz, CDCl3): δ 
3.03 (s, 3H), 3.83 (s, 3H), 4.24 (s, 3H), 6.94 (d, 2H, J 
= 8.8 Hz), 7. 86 (d, 2H, J = 8.8 Hz); 
13
C NMR: (300 
MHz, CDCl3): δ 23.72, 55.27, 60.31, 113.17, 114.10, 
121.13, 130.97, 150.78, 160.14, 167.23, 171.03; MS 
(70 eV): m/z 248 [M+H]
+
. Anal. Calcd for 
C13H13NO4: C, 63.15; H, 5.30; N, 5.67. Found: C, 
63.39; H, 5.48; N, 5.89%. 
 
1-Ethyl-3-methoxy-4-phenyl-1H-pyrrole-2,5-





H NMR: (300 MHz, CDCl3): δ 1.24 (t, 3H, J = 
7.2 Hz), 3.60 (q, 2H, J = 7.2 Hz), 4.23 (s, 3H), 7.35-
7.86 (m, 5H); MS (70 eV): m/z 232 [M+H]
+
. Anal. 
Calcd for C13H13NO3: C, 67.52; H, 5.67; N, 6.06. 
Found: C, 67.78; H, 5.82; N, 5.78%. 
 
3-(4-Chlorophenyl)-1-ethyl-4-methoxy-1H-





H NMR: (300 MHz, CDCl3): δ 
1.27 (t, 3H, J = 7.5 Hz), 3.64 (q, 2H, J = 7.5 Hz), 4.23 
(s, 3H), 7.41 (d, 2H, J = 8 Hz), 7.80 (d, 2H, J = 8 Hz); 
MS (70 eV): m/z 264 [M-H]
+
. Anal. Calcd for 
C13H112ClNO3: C, 58.77; H, 4.55; N, 5.27. Found: C, 
58.84; H, 4.64; N, 5.50%. 
 
1-Ethyl-3-methoxy-4-(4-methoxyphenyl)-1H-





H NMR: (300 MHz, CDCl3): δ 
1.10 (t, 3H, J = 7.2 Hz), 3.44 (q, 2H, J = 7.2 Hz), 3.78 
(s, 3H), 4.16 (s, 3H), 7.02 (d, 2H, J = 8.8 Hz), 7.77 (d, 
2H, J = 8.8 Hz); MS (70 eV): m/z 262 [M+H]
+
. Anal. 
Calcd for C14H15NO4: C, 64.36; H, 5.79; N, 5.36. 
Found: C, 64.68; H, 5.67; N, 5.58%. 
 
1-Benzyl-3-methoxy-4-phenyl-1H-pyrrole-2,5-dione, 




H NMR: (300 MHz, CDCl3): δ 4.25 (s, 3H), 4.71 (s, 
2H), 7.30-7.85 (m, 10H); 
13
C NMR: (300 MHz, 
CDCl3): δ 41.19, 60.33, 113.12, 127.78, 128.25, 
128.39, 128.52, 128.62, 128.65, 129.03, 136.38, 
151.56, 165.74, 169.73; MS (70 eV): m/z 294 
[M+H]
+
. Anal. Calcd for C18H15NO3: C, 73.71; H, 
5.15; N, 4.78. Found: C, 73.62; H, 5.31; N, 4.92%. 
 
1-Benzyl-3-(4-chlorophenyl)-4-methoxy-1H-pyrrole- 





H NMR: (300 MHz, CDCl3): δ 4.31 (s, 
3H), 4.69 (s, 2H), 7.31-7.87 (m, 9H); 
13
C NMR: (300 
MHz, CDCl3): δ 41.17, 60.44, 111.87, 126.97, 127.82, 
128.51, 128.66, 129.10, 130.07, 134.46, 136.23, 
151.57, 165.41, 169.41; MS (70 eV): m/z 326 [M-H]
+
. 
Anal. Calcd for C18H14ClNO3: C, 65.96; H, 4.31; N, 
4.27. Found: C, 65.69; H, 4.19; N, 4.38%. 










H NMR: (300 MHz, CDCl3): δ 
3.83 (s, 3H), 4.25 (s, 3H), 4.69 (s, 2H), 6.93 (d, 2H, J 
= 8.8 Hz), 7.87 (d, 2H, J = 8.8 Hz), 7.32-7.94 (m, 
5H); 
13
C NMR: (300 MHz, CDCl3): δ 41.01, 55.18, 
60.11, 113.73,121.01, 127.68, 128.41, 128.58, 129.30, 
130.38, 136.44, 149.98, 159.70, 165.94, 169.92; MS 
(70 eV): m/z 324 [M+H]
+
. Anal. Calcd for 
C19H17NO4: C, 70.58; H, 5.30; N, 4.33. Found: C, 
70.92; H, 5.43; N, 4.59%. 
 
1-(2-Hydroxyethyl)-3-methoxy-4-phenyl-1H-pyrrole-





H NMR: (300 MHz, CDCl3): δ 2.50 (bs, 1H), 
3.55 (d, 2H), 3.50 (d, 2H), 4.16 (s, 3H), 7.33-7.76 (m, 
5H); 
13
C NMR: (300 MHz, CDCl3): δ40.37, 60.38, 
60.81, 113.04, 128.26, 128.67, 129.06, 129.21, 
151.59, 166.38, 170.59; MS (70 eV): m/z 248 
[M+H]
+
. Anal. Calcd for C13H13NO4: C, 63.15; H, 
5.30; N, 5.67. Found: C, 63.37; H, 5.47; N, 5.91%. 
3-(4-Chlorophenyl)-1-(2-hydroxyethyl)-4-methoxy-
1H-pyrrole-2,5-dione, 5k: Yield 80%. IR: 1764, 




H NMR: (300 MHz, CDCl3): 
δ 2.33 (bs, 1H), 3.82 (d, 2H), 3.77 (d, 2H), 4.31 (s, 
3H), 7.36 (d, 2H, J = 6.3 Hz), 7.86 (d, 2H, J = 6.3 
Hz); 
13
C NMR: (300 MHz, CDCl3): δ 40.34, 60.47, 
60.85, 111.87, 126.78, 128.52, 130.08, 134.54, 
151.57, 166.07, 170.24; MS (70 eV): m/z 280 [M-H]
+
. 
Anal. Calcd for C13H12ClNO4: C, 55.43; H, 4.29; N, 
4.97. Found: C, 55.19; H, 4.17; N, 4.63%. 
 
1-(2-Hydroxyethyl)-3-methoxy-4-(4-methoxyphenyl)- 





H NMR: (300 MHz, CDCl3): δ 2.49 
(bs, 1H), 3.74 (d, 2H), 3.79 (d, 2H), 3.82 (s, 3H), 4.23 
(s, 3H), 6.94 (d, 2H, J = 8.7 Hz), 7.85 (d, 2H, J = 6.3 
Hz); 
13
C NMR: (300 MHz, CDCl3): δ 40.30, 55.18, 
60.15, 60.97, 113.40, 113.75, 120.80, 130.40, 150.01, 
159.75, 166.62, 170.79; MS (70 eV): m/z 278 [M+H]
+
. 
Anal. Calcd for C14H15NO5: C, 60.64; H, 5.45; N, 5.05. 
Found: C, 60.38; H, 5.29; N, 5.28%. 
 
Antimicrobial Assay 
The MIC values of all synthesized maleimides 
were carried out by broth microdilution method as 
described by Rattan
24
. From Institute of Microbial 
Technology Chandigarh, all the MTCC cultures were 
collected and tested against the standard antibacterial 
(Ampicillin) and antifungal (Griseofulvin) drugs. To 
grow the bacterial and fungal strains, Mueller Hinton 
broth was used as a nutrient medium and dilute the 
drug suspension for the test. The size of inoculum for 
test the strain was adjusted to 10
8
 CFU (Colony 
Forming Unit) per mL comparing the turbidity. 
Antimicrobial activity was screened against one gram 
positive bacteria (Staphylococcus aureus MTCC 96) 
and one gram negative bacteria (Escherichia coli 
MTCC 443) and four fungal strains (Candida 
albicans MTCC 227, Candida tropicalis MTCC 184, 
Aspergillus niger MTCC 282 and Aspergillus 
clavatus MTCC 1323). 
 
Conclusion 
Twelve novel 3-aryl-4-methoxy N-alkyl maleimide 
5a-l were synthesized using simple synthetic protocol 
with excellent yields. All synthesized maleimides 
were well characterizes and screened for their 
antifungal and antibacterial activity. On the basis of 
results obtained from antimicrobial screening it was 
concluded that maleimide derivatives possessing 
electron donating aryl (para methoxy and para 
chloro) substituent registered excellent antimicrobial 
activity. Tested compounds exhibited comparatively 
good activity against Gram positive (S. aureus) than 
Gram negative bacteria (E. coli). 
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